Clinical TrialsSearch results
Number of results: 66000
Completed
- A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
- Novel Coronavirus Infectious Disease (COVID-19)
- Ohmagari Norio
- 2020-03-24
Completed
- A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of the Preventive Effect of Naldemedine on Opioid-Induced Constipation
- neoplasms
- Jun Hamano
- 2021-03-05
Completed
- A multicenter, open-label study investigating efficacy and safety of GB-0998 for antibody-mediated rejection after renal transplant
- AMR after renal transplant
- Nakagawa Ken
- 2020-10-28
Completed
- A multicenter, open-label, randomized controlled phase II study to evaluate the efficacy and safety of inhaled ciclesonide for asymptomatic and mild patients with COVID-19
- COVID-19
- Sugiyama Haruhito
- 2020-03-27
Completed
- A Multicenter, Open-label, Uncontrolled Phase II study of ONO-4538 [immune-checkpoint inhibitor] for cutaneous angiosarcoma
- Advanced or recurrent cutaneous hemangiosarcoma
- Fujisawa Yasuhiro
- 2020-04-22
Completed
- A Multicenter, Prospective, Open Label, Single-Arm Study of a Novel Pain Management Device, AT-04, in Patients with Acute Low Back Pain
- Acute Low Back Pain
- Miki Kenji
- 2020-02-13
Completed
- A Multicenter, Prospective, Randomized Controlled Trial: SMC-01: A Mobile Medical Application to Improve Self-Management of Patients with Type 2 Diabetes
- Type 2 Diabetes
- Ohnishi Yukiko
- 2020-05-17
Completed
- A Multicenter, Randomized, Double-blind, Parallel-group, Placebo Controlled Study to Investigate the Use of Benralizumab for Eosinophilic Esophagitis
- Eosinophilic Esophagitis
- Hibi Kazushige
- 2020-11-04
Completed
- A Non-blinded Retrospective Biomarker add-on Study to FIGARO-DKD for Bioprofiling the Pharmacodynamic Response to Finerenone in FIGARO-DKD Subjects
- Chronic Kidney Disease /Type 2 Diabetes Mellitus
- Myoishi Masashi
- 2021-09-14
Completed
- A non-interventional, single-arm, multicentre, prospective study investigating the glycaemic control and treatment pattern associated with the use of Xultophy (IDegLira) in a real-world adult population with type 2 diabetes mellitus in Japan.(NN9068-4743)
- Type 2 Diebetes Mellitus
- Sudoh Yuki
- 2021-04-21